These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7064526)

  • 1. [Metabolic changes in the legs during treadmill exercise with and without arterial occlusive disease].
    Maass U; Konrad H; Fröhlich H; Alexander K
    Vasa; 1982; 11(1):9-14. PubMed ID: 7064526
    [No Abstract]   [Full Text] [Related]  

  • 2. [The walking-through phenomenon in arterial occlusive disease].
    Maass U; Goller B; Grothe R; Schneider B
    Vasa; 1995; 24(3):233-7. PubMed ID: 7676731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treadmill ergometry and muscular function in intermittent claudication].
    Bollinger A
    Schweiz Med Wochenschr; 1973 Apr; 103(17):636-41. PubMed ID: 4704805
    [No Abstract]   [Full Text] [Related]  

  • 4. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.
    Greiner A; Esterhammer R; Messner H; Biebl M; Mühlthaler H; Fraedrich G; Jaschke WR; Schocke MF
    J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methodology in angiologic-therapeutic-clinical research. Inter- and intra-individual comparison in arterial occlusive disease].
    Maass U
    Fortschr Med; 1983 Oct; 101(40):1831-7. PubMed ID: 6642390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH; Brinkmann G; Förger K; Gleim M; Wunsch-Binder F; Maier C; Zick G
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treadmill test for the assessment walking capacity of the patients with peripheral arterial occlusive disease].
    Sutkowska E; Dabrowska G; Dziubek V; Wysokiński W
    Pol Arch Med Wewn; 2001 Jun; 105(6):525-31. PubMed ID: 11865585
    [No Abstract]   [Full Text] [Related]  

  • 8. Regarding: "Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease".
    Hiatt WR
    J Vasc Surg; 2000 Mar; 31(3):611-2. PubMed ID: 10709078
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic effects of intermittent exercise by patients with stage II arterial occlusive disease].
    Maass U; Goller B; Grote R
    Vasa; 1995; 24(2):141-7. PubMed ID: 7793146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication.
    Afaq A; Montgomery PS; Scott KJ; Blevins SM; Whitsett TL; Gardner AW
    Angiology; 2008; 59(5):534-41. PubMed ID: 18388089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication.
    de Haro J; Acin F; Florez A; Bleda S; Fernandez JL
    J Vasc Surg; 2010 Apr; 51(4):857-62. PubMed ID: 20347681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bicycle ergometry in peripheral arterial occlusive disorders of the legs in stage II. 1: Tests on the principal suitability of the stress test on the bicycle ergometer].
    Schaller K
    Z Arztl Fortbild (Jena); 1982 Aug; 76(16):718-20. PubMed ID: 7148007
    [No Abstract]   [Full Text] [Related]  

  • 13. [Regional blood flow and oxygen consumption in the leg muscles of normal subjects and in those with arterial insufficiency. Study of the distribution of C15O2 and of 15O2 using positron emission tomography].
    Depairon M; Depresseux JC; De Landsheere C; Merlo P; Del Fiore G; Quaglia L; Peeters JM; Lamotte D; Zicot M
    J Mal Vasc; 1988; 13(2):107-15. PubMed ID: 3260934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle metabolism during exercise in patients with occlusive arterial disease: effect of reconstructive surgery.
    Pernow B; Saltin B; Wahren J; Cronestrand R
    Scand J Clin Lab Invest Suppl; 1973; 128():21-5. PubMed ID: 4764586
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.
    Izquierdo-Porrera AM; Gardner AW; Powell CC; Katzel LI
    J Vasc Surg; 2000 Apr; 31(4):670-7. PubMed ID: 10753274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of peripheral occlusive arterial disease].
    Tønnesen KH; Noer I; Paaske W; Sager P
    Ugeskr Laeger; 1981 Nov; 143(49):3280-2. PubMed ID: 7331038
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of treadmill walking and stair climbing over a range of exercise intensities in peripheral vascular occlusive disease.
    Gardner AW; Skinner JS; Vaughan NR; Bryant CX; Smith LK
    Angiology; 1993 May; 44(5):353-60. PubMed ID: 8480912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intermittent claudication in patients with peripheral arterial occlusive disease relieved under hyperbaric conditions?
    Sakurai T; Mano N; Matsushita M; Nishikimi N; Nimura Y; Takashashi H
    Vasa; 1997 Nov; 26(4):317-8. PubMed ID: 9409184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regional hemodynamic changes induced by muscular exercise in subjects with obliterating arteriopathy of the lower extremities: effect of beta receptor blocking].
    Brevetti G; Paudice G; Lavecchia G; De Caprio L; Ferro G; D'Ascia C; Orefice U
    Boll Soc Ital Cardiol; 1977; 22(7):1094-100. PubMed ID: 36115
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen saturation measurement of calf muscle during exercise in intermittent claudication.
    Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2002 May; 23(5):388-92. PubMed ID: 12027464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.